1. Lapatinib versus lapatinib plus capecitabine as second-line treatment in human epidermal growth factor receptor 2-amplified metastatic gastro-oesophageal cancer: A randomised phase II trial of the Arbeitsgemeinschaft Internistische Onkologie. Issue 5 (March 2015) Authors: Lorenzen, Sylvie; Riera Knorrenschild, Jorge; Haag, Georg-Martin; Pohl, Michael; Thuss-Patience, Peter; Bassermann, Florian; Helbig, Ulrike; Weißinger, Florian; Schnoy, Elisabeth; Becker, Klaus; Stocker, Gertraud; Rüschoff, Josef; Eisenmenger, Andreas; Karapanagiotou-Schenkel, Irini; Lordick, Flo... Journal: European journal of cancer Issue: Volume 51:Issue 5(2015:Mar.) Page Start: 569 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗